Antibody patterns may predict inflammatory bowel disease a decade early

Research presented at United European Gastroenterology Week 2026 indicates that specific antibody patterns in the blood could predict the onset of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, up to ten years before clinical diagnosis.

Studies involving serum specimens from U.S. military personnel revealed that the immune system undergoes pathological changes long before symptoms appear and intestinal damage occurs. For instance, individuals who later developed Crohn’s disease showed elevated antibody responses against herpesviruses, such as the Epstein-Barr virus, and flagellin. Conversely, those with ulcerative colitis exhibited a distinct profile, reacting to specific proteins within the body.

Additionally, research involving cohorts in Sweden and Norway demonstrated that gut microbiome composition can serve as a classifier to predict aggressive disease courses in newly diagnosed ulcerative colitis patients. These findings offer potential pathways for earlier risk stratification, personalized treatment, and the possibility of future prevention.